Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce hiv-1 remission

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 1, 2001, Pages 44-55

  Lafeuillade, Alain ^a,b   Poggi, Cécile ^a   Chadapaud, Stéphane ^a   Hittinger, Gilles ^a   Chouraqui, Martine ^a   Pisapia, Magali ^a   Delbeke, Emmanuel ^a  

^a GENERAL HOSPITAL   (France)

^b Hopital Chalucet Toulon   (France)

Author keywords

Cytokines; HAART; HIV; IL 2; Immune intervention; Residual viral pool

Indexed keywords

ANTIRETROVIRUS AGENT; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 2; LAMIVUDINE; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE CELL; LYMPHOID TISSUE; MALE; MEMORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; REMISSION; T LYMPHOCYTE SUBPOPULATION; VIRUS CULTURE; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0035144503     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200101010-00006     Document Type: Article

References (40)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres
3. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
4. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy
5. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
6. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
7. How immune-based interventions can change HIV therapy
8. + T cells using a combination of cytokines
9. Towards HIV eradication or remission: The tasks ahead
10. Detection of low HIV-1 RNA levels in plasma
11. Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments
12. Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay
13. Recovery of replication-competent HIV despite prolonged suppression of plasma viraemia
14. A novel mode of Human Immunodeficiency Virus type 1 (HIV-1) activation: Ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes
15. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy
16. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
17. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
18. Ritonavir and saquinavir combination therapy for the treatment of HIV infection
19. A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infection
20. Lymph node human immunodeficiency virus RNA levels and resistance mutations in patients receiving high-dose saquinavir
21. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine
22. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
23. Ongoing dissemination during HAART
24. Multiple modes of cellular activation and virus transmission in HIV infection: A role for chronically and latently infected cells in sustaining viral replication
25. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
26. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
27. Re-emergence of HIV after stopping therapy
28. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
29. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
30. + T cells using a combination of cytokines
31. HIV-1 rebound after anti-retroviral therapy
32. Relationship between preexisting latent viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active antiretroviral therapy
33. Antiretroviral drug resistance testing in adult HIV-1 infection
34. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy
35. + T cell homeostasis and function in advanced HIV disease
36. + T-helper cells
37. + naive T cells following triple-drug therapy for HIV type 1 infection
38. + T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study
39. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
40. + T lymphocytes during HIV-1 infection